18f-fluorobenzyl triphenyl phosphonium
18f-fluorobenzyl triphenyl phosphonium - a radioconjugate and cationic lipophilic agent consisting of fluorobenzyl triphenyl phosphonium (fbntp), labeled with the radioisotope fluorine f 18, with potential use as a tracer for both mitochondrial membrane potential (mmp) and apoptosis, and as a tumor imaging agent using positron emission tomography (pet). Upon administration, fluorine f 18 fbntp is taken up by cells and its uptake and accumulation within mitochondria is directly correlated with mmp. Apoptosis causes a loss of membrane potential across the inner mitochondrial membrane which decreases fbntp mitochondrial uptake. As apoptosis is suppressed in tumor cells, the fbntp uptake is increased as compared to normal cells. This allows, upon pet, for the imaging of cancer cells. As apoptotic-inducing chemotherapeutic agents cause a collapse of mmp, this agent can also be used to assess the response of tumor cells to those chemotherapeutic agents. Also see fluorine f 18 fluorobenzyl triphenyl phosphonium
Up to date info
Latest research - 18f-fluorobenzyl triphenyl phosphonium
|This medical article is a stub. You can help WikiMD by expanding it.|
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on 18f-fluorobenzyl triphenyl phosphonium for any updates.